MemoMCI study launch: the European Commission is funding research to improve memory

MemoMCI is a study, funded by the European Commission (Marie Sklodowska-Curie Actions, the Horizon 2020 program), aiming at improving episodic memory through a non-pharmacological treatment in elderly individuals with Mild Cognitive Impairment (MCI).

Since September 2016, following approval of Ethical Committee, the Principal Investigator Dr. Marco Sandrini has initiated research at the Casa di Cura del Policlinico with the scientific supervision of Dr. Massimo Corbo, Scientific Director of the Department of Neuroriabilitative Sciences of CCP.

The aim of the study is to identify individuals with mild cognitive impairment (MCI) who will benefit most from treatment with non-invasive electrical stimulation (tDCS) based on integrity of some aspects found on their MRI exams and in relation to the characteristics of some of their genes associated with memory.

For further information click here

Call

Horizon 2020 – EU Framework Program for Scientific Research and Innovation Excellence Marie- Sklodowska-Curie Actions (MCSA) – Reintegration Panel in European Fellowship (EF).

Study Title

Targeting reconsolidation to strengthen memories in individuals with mild cognitive impairment. RI-Reintegration panel; Proposal number: 658496; Proposal acronym: MemoMCI; Official link

Leaders

Dr. Marco Sandrini, Principal Investigator

Dr. Massimo Corbo, Scientific Supervisor

Dr. Alessia Monti, Co-Investigator

Contacts

Researcher: Dr. Marco Sandrini

Mail: m.sandrini@ccppdezza.it

Project Coordinator: Ms. Valentina Brunati

Office design +39 0248593514

Mail: v.brunati@ccppdezza.it